F-Prime Capital

Rippl Care is a mental health company based in Seattle, Washington, dedicated to supporting seniors experiencing dementia and other neurocognitive disorders. Founded in 2021, the company employs a value-based approach and innovative technology to deliver comprehensive care tailored to individual needs. By prioritizing the empowerment of its clinicians, Rippl Care adopts a novel care model that enables seniors to receive personalized support through various channels, including phone, online, and in-home visits. This commitment to enhancing the quality of care for those affected by neurocognitive conditions sets Rippl Care apart in the mental health landscape.

RareCyte, Inc. is a life sciences company based in Seattle, Washington, founded in 2009. The company specializes in developing advanced platforms for liquid and tissue biopsy analysis, focusing on the detection and characterization of rare cells, particularly circulating tumor cells (CTCs) and circulating endothelial cells (CECs) in blood samples. RareCyte's AccuCyte system provides an open platform that facilitates the unbiased discovery and isolation of these rare cells, supporting various applications in cancer research, cardiovascular disease studies, and diagnostic development. The company offers a range of products, including sample preparation systems, staining kits, automated fluorescence microscopy instruments, and slide imaging systems. By enabling precision medicine approaches, RareCyte aims to provide new tools for medical professionals and researchers to address complex questions in the fields of cancer and other therapeutic areas.

Cadence Neuroscience develops implantable medical device therapies for epilepsy, central pain, and other neurological disorders. Founded in 2017 and based in Redmond, Washington, the company pursues core technology developed at Mayo Clinic that is being evaluated clinically. The device detects brain signals and delivers electrical stimulation to modulate neural circuits, enabling personalized brain stimulation to improve seizure control relative to existing protocols.

Rippl Care is a mental health company based in Seattle, Washington, dedicated to supporting seniors experiencing dementia and other neurocognitive disorders. Founded in 2021, the company employs a value-based approach and innovative technology to deliver comprehensive care tailored to individual needs. By prioritizing the empowerment of its clinicians, Rippl Care adopts a novel care model that enables seniors to receive personalized support through various channels, including phone, online, and in-home visits. This commitment to enhancing the quality of care for those affected by neurocognitive conditions sets Rippl Care apart in the mental health landscape.

Founded in 2016, Latchel operates an online platform that streamlines maintenance coordination for property managers and landlords. Its platform enables tracking of maintenance requests, vendor selection, and mobile communication with tenants, aiming to increase net margins and renter satisfaction.

Founded in 2016, Logixboard is a Seattle-based company that develops cloud platforms for freight forwarders. Its software increases transparency and communication with customers, helping logistics service providers enhance sales and customer retention.

RareCyte, Inc. is a life sciences company based in Seattle, Washington, founded in 2009. The company specializes in developing advanced platforms for liquid and tissue biopsy analysis, focusing on the detection and characterization of rare cells, particularly circulating tumor cells (CTCs) and circulating endothelial cells (CECs) in blood samples. RareCyte's AccuCyte system provides an open platform that facilitates the unbiased discovery and isolation of these rare cells, supporting various applications in cancer research, cardiovascular disease studies, and diagnostic development. The company offers a range of products, including sample preparation systems, staining kits, automated fluorescence microscopy instruments, and slide imaging systems. By enabling precision medicine approaches, RareCyte aims to provide new tools for medical professionals and researchers to address complex questions in the fields of cancer and other therapeutic areas.

Founded in 2016, Logixboard is a Seattle-based company that develops cloud platforms for freight forwarders. Its software increases transparency and communication with customers, helping logistics service providers enhance sales and customer retention.

Founded in 2018, Sana Biotechnology focuses on creating and delivering engineered cells as medicine for patients. The company aims to reprogram cells in the body or replace damaged ones to treat a broad range of diseases, with a pipeline including SC291, SC262, SC255, UP421, and other candidates across therapeutic areas like oncology, diabetes, autoimmune disorders, and CNS.

NodThera is a UK-based biotechnology company focused on developing novel inhibitors of the NLRP3 inflammasome for treating inflammatory and neuroinflammatory diseases. Established in 2016, it operates laboratories in Little Chesterford (UK) and Seattle (US), with corporate offices in Lexington (US). The company's primary research involves inflammasomes, multi-protein complexes targeting conditions such as arthritis, atherosclerosis, Alzheimer's disease, diabetes, and certain cancers.

Avalyn Pharma is a biopharmaceutical company focused on developing therapies for severe respiratory diseases, notably idiopathic pulmonary fibrosis (IPF). Established in 2011, the company is headquartered in Seattle, Washington.

Founded in 2016, Logixboard is a Seattle-based company that develops cloud platforms for freight forwarders. Its software increases transparency and communication with customers, helping logistics service providers enhance sales and customer retention.

RiskLens, Inc. is a provider of cyber risk management software based in Spokane, Washington. Founded in 2011, the company offers a suite of applications designed to help organizations quantify and manage their cyber risk from a business perspective. Its key products include Cyber Risk Maturity, which assesses an organization's risk management capabilities and compliance; Cyber Risk Triage, a tool for rapid risk assessment; Cyber Risk Third-Party, which evaluates the risk management practices of external partners; and Cyber Risk Quantification, a decision-support application that calculates financial exposure to cybersecurity events. Additionally, RiskLens provides professional services, training, and certification to support its clients. The company's solutions are aimed at various sectors, including financial services, government, healthcare, education, and technology, empowering executives and risk officers to make informed cybersecurity investment decisions and manage their cyber risk effectively.

Founded in 2018, Sana Biotechnology focuses on creating and delivering engineered cells as medicine for patients. The company aims to reprogram cells in the body or replace damaged ones to treat a broad range of diseases, with a pipeline including SC291, SC262, SC255, UP421, and other candidates across therapeutic areas like oncology, diabetes, autoimmune disorders, and CNS.

Founded in 2018, Sana Biotechnology focuses on creating and delivering engineered cells as medicine for patients. The company aims to reprogram cells in the body or replace damaged ones to treat a broad range of diseases, with a pipeline including SC291, SC262, SC255, UP421, and other candidates across therapeutic areas like oncology, diabetes, autoimmune disorders, and CNS.

NodThera is a UK-based biotechnology company focused on developing novel inhibitors of the NLRP3 inflammasome for treating inflammatory and neuroinflammatory diseases. Established in 2016, it operates laboratories in Little Chesterford (UK) and Seattle (US), with corporate offices in Lexington (US). The company's primary research involves inflammasomes, multi-protein complexes targeting conditions such as arthritis, atherosclerosis, Alzheimer's disease, diabetes, and certain cancers.

Avalyn Pharma is a biopharmaceutical company focused on developing therapies for severe respiratory diseases, notably idiopathic pulmonary fibrosis (IPF). Established in 2011, the company is headquartered in Seattle, Washington.

VitalWare, LLC is a provider of revenue cycle software-as-a-service (SaaS) solutions tailored for healthcare organizations. Established in 2011 and based in Yakima, Washington, the company offers a comprehensive suite of products designed to enhance efficiency in documentation, coding, billing, and auditing processes. Key offerings include VitalCDM, which streamlines hospital chargemaster management; VitalCDI, a tool that enhances clinical documentation; and VitalIntelligence, which assists with regulatory compliance. Additionally, VitalWare provides professional services that support healthcare providers in coding guidance, process improvement, and financial impact analysis. With a client base of over 590 healthcare institutions, VitalWare aims to help its partners achieve optimal reimbursement and maintain a healthier revenue cycle through innovative cloud-based technologies and expert regulatory content.

FutureAdvisor, founded in 2010 and based in Seattle, Washington, offers investment advisory services that aim to simplify wealth management for clients. The company specializes in providing personalized, data-driven recommendations to optimize retirement accounts such as 401(k)s and IRAs. FutureAdvisor's platform focuses on delivering financial projections and tailored diversification plans, helping clients make informed investment decisions. By implementing the principles of index investing in a user-friendly software format, FutureAdvisor addresses common investment challenges, such as high fees and poor performance associated with traditional mutual funds. As a subsidiary of BlackRock, FutureAdvisor continues to promote the notion that effective investing can be accessible and affordable for everyone.